Rhodium(<scp>iii</scp>)-catalyzed oxidative alkylation of <i>N</i>-aryl-7-azaindoles with cyclopropanols
作者:Jidan Liu、Jinyuan Jiang、Zhenke Yang、Qiaohai Zeng、Jieying Zheng、Siying Zhang、Liyao Zheng、Shang-Shi Zhang、Zhao-Qing Liu
DOI:10.1039/d0ob02323j
日期:——
An efficient Rh(III)-catalyzed C–Hoxidative alkylation of N-aryl-7-azaindoles with cyclopropanols by merging tandemC–H and C–Ccleavage was developed. This transformation features mild reaction conditions, high regioselectivity, and excellent functional group compatibility. The resulting β-aryl ketone derivatives can be readily transformed into 7-azaindole-containing π-extended polycyclic heteroarenes
Iridium-catalyzed C–H phosphoramidation of <i>N</i>-aryl-7-azaindoles with phosphoryl azides
作者:Changduo Pan、Yun Wang、Chao Wu、Jin-Tao Yu
DOI:10.1039/c8ob00776d
日期:——
An iridium-catalyzed C–H phosphoramidation of N-aryl-7-azaindoles with phosphoryl azides was developed, affording a series of 7-azaindole phenylphosphoramidates in moderate to good yields. This protocol displays good functional group tolerance, which offers a novel and direct approach to access 7-azaindole phenylphosphoramidates.
The invention pertains to heteroaromatic compounds of the formula I,
as defined herein, that serve as effective phosphodiesterase (PDE) inhibitors. In particular, the invention relates to said compounds which are selective inhibitors of PDE10. The invention also relates to pharmaceutical compositions comprising said compounds; and the use of said compounds in a method for treating certain central nervous system (CNS) or other disorders.